Biography and Research Information
OverviewAI-generated summary
Farah Mazahvreh is a graduate student at the University of Arkansas for Medical Sciences. Her research focuses on the duration of immune checkpoint inhibitors (ICI) in oncology. Mazahvreh has one publication detailing findings that suggest longer durations of ICI treatment may not necessarily lead to improved outcomes in cancer patients, indicating a potential need to re-evaluate treatment protocols. She collaborates with researchers Liyan Mazahreh, Ahmad Mazin M. Safar, A. Mazin Safar, and Samuel L. Schach, all affiliated with the University of Arkansas for Medical Sciences, on shared publications.
Metrics
- Publications: 1
Selected Publications
-
Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better (2025)
Collaboration Network
Top Collaborators
- Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better
- Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better
- Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better
Similar Researchers
Based on overlapping research topics